Skip to content
  • Join Us
  • Members Area
ASOI
  • Home
  • ASOI News
  • About Us
  • Events
  • Media Resources
  • Public Resources
  • Guidelines
  • Research

Publication Category: Weight Loss/Management

Community pharmacists’ experiences and perspectives on GLP-1 receptor agonists for obesity management: a cross-sectional study in Ireland

  • Demmel J, Farrell C, Timon CM, Cleary O, Christie HL, O'Leary N, George CV, Dunne P, Mitchell S, le Roux CW, O'Hara C, Flood M, Flynn AC. Community pharmacists’ experiences and perspectives on GLP-1 receptor agonists for obesity management: a cross-sectional study in Ireland Int J Pharm Pract

Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis

  • Nong K, Shi Q, Xie X, Wang Y, Agarwal A, Guyatt GH, Zhang H, Gao Y, Khunti K, Le Roux CW, Widyahening IS, Fan Q, Liu T, Mao Y, Florez ID, Du H, Pan X, Zou X, Wang C, Sun X, Li J, Hao Q, Jia Q, Sun F, Zhu Z, Agoritsas T, Tian H, Vandvik PO, Li S. Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis BMJ

Mapping Obesity Care Pathways and Healthcare Resource Use From 2015 to 2019 in England

  • Miras AD, Capucci S, Migas S, Wrona B, Zhao L, Castañeda-Sanabria J, Hagelund LM, Antavalis V, Morgen CS. Mapping Obesity Care Pathways and Healthcare Resource Use From 2015 to 2019 in England Obes Sci Pract

Obesity Remission: A Missing Target in Contemporary Medicine

  • Koufakis T, Kokkinos A, Busetto L, le Roux CW. Obesity Remission: A Missing Target in Contemporary Medicine Obes Rev

GLP-1 receptor agonists and weight-loss strategies for individuals with obesity and hip or knee osteoarthritis: a scoping review

  • McCann C, Clement N, Murray A, Kearney R, Madigan S, Gee C, Walmsley P, Morrison S, Chopra S, Hall A. GLP-1 receptor agonists and weight-loss strategies for individuals with obesity and hip or knee osteoarthritis: a scoping review Br J Sports Med

How does survodutide work? Plain language review of a potential new medication for obesity and liver disease

  • Almandoz JP, Miras AD, Seufert J, Paul E. How does survodutide work? Plain language review of a potential new medication for obesity and liver disease Ther Adv Gastroenterol

    MASLD

Survodutide Once Weekly for the Treatment of Adults with Obesity

  • le Roux CW, Wharton S, Startseva E, Kloer IM, Hussain SA, Unseld A, Bozkurt B, Ard JD, Bays HE, Bogdański P, Ekinci EI, Jastreboff AM, Ji L, Ogawa W, Pedersen SD, Pietiläinen KH, Sattar N, Seufert J, Stenlöf K, van Beek AP, Vangoitsenhoven R, Brueckmann M Survodutide Once Weekly for the Treatment of Adults with Obesity N Engl J Med

Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review

  • Mady R, Tafazal H, Soliman H, Ramadan A, Hajaj M. Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review Cureus

Ovulatory Recovery following weight loss in women with polycystic ovary syndrome and obesity: a post hoc analysis of the BAMBINI randomised controlled trial

  • Hum Reprod Ovulatory Recovery following weight loss in women with polycystic ovary syndrome and obesity: a post hoc analysis of the BAMBINI randomised controlled trial Hum Reprod

    PCOS

Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial

  • Horn DB, Aronne LJ, Wharton S, Bays HE, le Roux CW, Srinath R, Gomez-Valderas E, Arad AD, Das S, Dunn JP, Ribeiro A, Glass LC, Lee CJ. Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Lancet

Older posts
Page1 Page2 … Page27 Next →

Recent Posts

  • 10th ASOI Annual Scientific Meeting 2026
  • 9th ASOI Annual Conference – Registration now open!
  • Press Release for World Obesity Day 4th March 2024
  • ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
  • Things to do in Dublin during ECO

ASOI

  • info@asoi.info
  • Home
  • ASOI News
  • About Us
  • Events
  • Media Resources
  • Public Resources
  • Guidelines
  • Research
  • Home
  • ASOI News
  • About Us
  • Events
  • Media Resources
  • Public Resources
  • Guidelines
  • Research
  • Privacy Policy
  • Site Map

©2026 ASOI